Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paul Martin
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Concepts & Ideas
Anatomy
Living Beings
Sign-in to see full Profile
Network (preview)
75
Hansen, John
69
Anasetti, Claudio
59
Storb, Rainer
58
Appelbaum, Frederick
50
Petersdorf, Effie
36
Flowers, Mary
33
Sanders, Jean
28
Deeg, Joachim
23
Mickelson, Eric
21
Doney, Kristine
21
Nash, Richard
19
Press, Oliver
18
Gooley, Ted
18
Witherspoon, Robert
17
Storer, Barry
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paul Martin (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Martin Paul J; Bachier Carlos R; Klingemann Hans-Georg; McCarthy Philip L; Szabolcs Paul; Uberti Joseph P; Schuster Michael W; Weisdorf Daniel; Chao Nelson J; Kebriaei Partow; Shpall Elizabeth J; Macmillan Margaret L; Soiffer Robert J
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):777-84.
-
2009: Carnevale-Schianca Fabrizio; Leisenring Wendy; Martin Paul J; Furlong Terry; Schoch Gary; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Kiem Hans-Peter; Storb Rainer; McDonald George B; Nash Richard A
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
-
2009: Martin Paul J; Storer Barry E; Rowley Scott D; Flowers Mary E D; Lee Stephanie J; Carpenter Paul A; Wingard John R; Shaughnessy Paul J; DeVetten Marcel P; Jagasia Madan; Fay Joseph W; van Besien Koen; Gupta Vikas; Kitko Carrie; Johnston Laura J; Maziarz Richard T; Arora Mukta; Jacobson Pamala A; Weisdorf Daniel
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Blood 2009;113(21):5074-82.
-
2009: Lee Stephanie J; Seaborn Travis; Mao Frances J; Massey Susan C; Luu Ngoc Q; Schubert Mary A; Chien Jason W; Carpenter Paul A; Moravec Carina; Martin Paul J; Flowers Mary E D
Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):416-20.
-
2009: Tseng Li-Hui; Storer Barry; Petersdorf Effie; Lin Ming-Tseh; Chien Jason W; Grogan Bryan M; Malkki Mari; Chen Pei-Jer; Zhao Lue P; Martin Paul J; Hansen John A
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.
Transplantation 2009;87(5):704-10.
-
2009: Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
-
2009: Martin Paul J; Pavletic Steven Z
Biology and management of chronic graft-versus-host disease.
Cancer treatment and research 2009;144():1-22.
-
2008: Martin Paul J
Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.
The Keio journal of medicine 2008;57(4):177-83.
-
2008: Flowers Mary E D; Storer Barry; Carpenter Paul; Rezvani Andrew R; Vigorito Afonso C; Campregher Paulo V; Moravec Carina; Kiem Hans-Peter; Fero Matthew; Georges George; Warren Edus; Lee Stephanie; Sanders Jean E; Appelbaum Fred; Martin Paul J
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1380-4.
-
2008: Xhaard A; Porcher R; Chien J W; de Latour R P; Robin M; Ribaud P; Rocha V; Devergie A; Ferry C; Martin P J; Socié G
Impact of comorbidity indexes on non-relapse mortality.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(11):2062-9.
-
2008: Martin Paul J
Study design and endpoints in graft-versus-host disease.
Best practice & research. Clinical haematology 2008;21(2):357-72.
-
2008: Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
-
2008: Sala-Torra O; Martin P J; Storer B; Traina F; Sorror M L; Storb R; Sandmaier B M; Flowers M E D
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.
Bone marrow transplantation 2008;41(10):887-93.
-
2008: Sorror Mohamed L; Storer Barry E; Maloney David G; Sandmaier Brenda M; Martin Paul J; Storb Rainer
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
-
2007: Mielcarek Marco; Storer Barry E; Sandmaier Brenda M; Sorror Mohamed L; Maloney David G; Petersdorf Effie; Martin Paul J; Storb Rainer
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
-
2007: Campregher P V; Gooley T; Scott B L; Moravec C; Sandmaier B; Martin P J; Deeg H J; Warren E H; Flowers M E D
Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
Bone marrow transplantation 2007;40(10):965-71.
-
2007: Mielcarek Marco; Storer Barry E; Flowers Mary E D; Storb Rainer; Sandmaier Brenda M; Martin Paul J
Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1160-8.
-
2007: Malone F R; Leisenring W M; Storer B E; Lawler R; Stern J M; Aker S N; Bouvier M E; Martin P J; Batchelder A L; Schoch H G; McDonald G B
Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant.
Bone marrow transplantation 2007;40(8):765-72.
-
2007: Takahide Kikuchi; Parker Pablo M; Wu Michael; Hwang William Y K; Carpenter Paul A; Moravec Carina; Stehr Barbara; Martin Paul J; Rosenthal Perry; Forman Stephen J; Flowers Mary E D
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1016-21.
-
2007: Dallas Mari H; Varnum-Finney Barbara; Martin Paul J; Bernstein Irwin D
Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.
Blood 2007;109(8):3579-87.
-
2007: Carpenter Paul A; Snyder David S; Flowers Mary E D; Sanders Jean E; Gooley Theodore A; Martin Paul J; Appelbaum Frederick R; Radich Jerald P
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
Blood 2007;109(7):2791-3.
-
2007: Petersdorf Effie W; Malkki Mari; Gooley Ted A; Martin Paul J; Guo Zhen
MHC haplotype matching for unrelated hematopoietic cell transplantation.
PLoS medicine 2007;4(1):e8.
-
2006: Leisenring Wendy M; Martin Paul J; Petersdorf Effie W; Regan Anne E; Aboulhosn Nada; Stern Jean M; Aker Saundra N; Salazar Raymond C; McDonald George B
An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.
Blood 2006;108(2):749-55.
-
2006: Erard Veronique; Chien Jason W; Kim Hyung W; Nichols W Garrett; Flowers Mary E; Martin Paul J; Corey Lawrence; Boeckh Michael
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.
The Journal of infectious diseases 2006;193(12):1619-25.
-
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
-
2006: Martin Paul J; Weisdorf Daniel; Przepiorka Donna; Hirschfeld Steven; Farrell Ann; Rizzo J Douglas; Foley Ronan; Socie Gerard; Carter Shelly; Couriel Daniel; Schultz Kirk R; Flowers Mary E D; Filipovich Alexandra H; Saliba Rima; Vogelsang Georgia B; Pavletic Steven Z; Lee Stephanie J;
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):491-505.
-
2006: Burroughs Lauri; Mielcarek Marco; Leisenring Wendy; Sandmaier Brenda M; Maloney David G; Baron Frédéric; Martin Paul J; Flowers Mary E D; Forman Stephen J; Chauncey Thomas R; Bruno Benedetto; Storb Rainer
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
-
2006: Parimon Tanyalak; Au David H; Martin Paul J; Chien Jason W
A risk score for mortality after allogeneic hematopoietic cell transplantation.
Annals of internal medicine 2006;144(6):407-14.
-
2006: Pagel John M; Appelbaum Frederick R; Eary Janet F; Rajendran Joseph; Fisher Darrell R; Gooley Ted; Ruffner Katherine; Nemecek Eneida; Sickle Eileen; Durack Larry; Carreras Jeanette; Horowitz Mary M; Press Oliver W; Gopal Ajay K; Martin Paul J; Bernstein Irwin D; Matthews Dana C
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
Blood 2006;107(5):2184-91.
-
2006: Martin Paul J; Nash Richard A
Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):31-6.
-
2005: Lin Ming-Tseh; Storer Barry; Martin Paul J; Tseng Li-Hui; Grogan Bryan; Chen Pei-Jer; Zhao Lue P; Hansen John A
Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.
Blood 2005;106(12):3995-4001.
-
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(10):814-5.
-
2005: Syrjala Karen L; Langer Shelby L; Abrams Janet R; Storer Barry E; Martin Paul J
Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6596-606.
-
2005: Kahl Christoph; Leisenring Wendy; Deeg H Joachim; Chauncey Thomas R; Flowers Mary E D; Martin Paul J; Sanders Jean E; Storb Rainer
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
British journal of haematology 2005;130(5):747-51.
-
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):567-8.
-
2005: Nash Richard A; Johnston Laura; Parker Pablo; McCune Jeannine S; Storer Barry; Slattery John T; Furlong Terry; Anasetti Claudio; Appelbaum Frederick R; Lloid Michele E; Deeg H Joachim; Kiem Hans-Peter; Martin Paul J; Schubert Mark M; Witherspoon Robert P; Forman Stephen J; Blume Karl G; Storb Rainer
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
-
2005: Mielcarek Marco; Burroughs Lauri; Leisenring Wendy; Diaconescu Razvan; Martin Paul J; Sandmaier Brenda M; Maloney David G; Maris Michael B; Chauncey Thomas R; Shizuru Judith A; Blume Karl G; Hegenbart Ute; Niederwieser Dietger; Forman Stephen; Bruno Benedetto; Woolfrey Ann; Storb Rainer
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
-
2005: Mielcarek Marco; Gooley Theodore; Martin Paul J; Chauncey Thomas R; Young Bessie A; Storb Rainer; Torok-Storb Beverly
Effects of race on survival after stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):231-9.
-
2005: Flowers M E D; Traina F; Storer B; Maris M; Bethge W A; Carpenter P; Appelbaum F; Storb R; Sandmaier B M; Martin P J
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
Bone marrow transplantation 2005;35(3):277-82.
-
2005: Albert Michael H; Yu Xue-Zhong; Martin Paul J; Anasetti Claudio
Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin.
Blood 2005;105(3):1355-61.
-
2005: Martin Paul J; Friedman Debra
How can hematopoietic cell transplant centers and referring physicians help each other during long-term follow-up?
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():250-4.
-
2004: Stewart Betty L; Storer Barry; Storek Jan; Deeg H Joachim; Storb Rainer; Hansen John A; Appelbaum Frederick R; Carpenter Paul A; Sanders Jean E; Kiem Hans-Peter; Nash Richard A; Petersdorf Effie W; Moravec Carina; Morton A James; Anasetti Claudio; Flowers Mary E D; Martin Paul J
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
-
2004: Petersdorf Effie W; Anasetti Claudio; Martin Paul J; Gooley Ted; Radich Jerald; Malkki Mari; Woolfrey Ann; Smith Anajane; Mickelson Eric; Hansen John A
Limits of HLA mismatching in unrelated hematopoietic cell transplantation.
Blood 2004;104(9):2976-80.
-
2004: Martin Paul J; Pei Ji; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Deeg Joachim; Hansen John A; Nash Richard A; Petersdorf Effie W; Storb Rainer; Ghetie Victor; Schindler John; Vitetta Ellen S
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):552-60.
-
2004: Yu Xue-Zhong; Albert Michael H; Martin Paul J; Anasetti Claudio
CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
The Journal of clinical investigation 2004;113(11):1624-30.
-
2004: Syrjala Karen L; Langer Shelby L; Abrams Janet R; Storer Barry; Sanders Jean E; Flowers Mary E D; Martin Paul J
Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.
JAMA : the journal of the American Medical Association 2004;291(19):2335-43.
-
2004: Martin Paul J; McDonald George B; Sanders Jean E; Anasetti Claudio; Appelbaum Frederick R; Deeg H Joachim; Nash Richard A; Petersdorf Effie W; Hansen John A; Storb Rainer
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
-
2004: Martin Paul J; Carpenter Paul A; Sanders Jean E; Flowers Mary E
Diagnosis and clinical management of chronic graft-versus-host disease.
International journal of hematology 2004;79(3):221-8.
-
2004: Chien J W; Martin P J; Flowers M E; Nichols W G; Clark J G
Implications of early airflow decline after myeloablative allogeneic stem cell transplantation.
Bone marrow transplantation 2004;33(7):759-64.
-
2004: Mielcarek Marco; Martin Paul J; Heimfeld Shelly; Storb Rainer; Torok-Storb Beverly
CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Leukemia & lymphoma 2004;45(1):27-34.
-
2003: Lin Ming-Tseh; Storer Barry; Martin Paul J; Tseng Li-Hui; Gooley Ted; Chen Pei-Jer; Hansen John A
Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.
The New England journal of medicine 2003;349(23):2201-10.
-
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
-
2003: Akatsuka Yoshiki; Warren Edus H; Gooley Ted A; Brickner Anthony G; Lin Ming-Tseh; Hansen John A; Martin Paul J; Madtes David K; Engelhard Victor H; Takahashi Toshitada; Riddell Stanley R
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling.
British journal of haematology 2003;123(4):671-5.
-
2003: Gopal Ajay K; Gooley Theodore A; Maloney David G; Petersdorf Stephen H; Eary Janet F; Rajendran Joseph G; Bush Sharon A; Durack Lawrence D; Golden Jane; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.
Blood 2003;102(7):2351-7.
-
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
-
2003: Fukuda Takahiro; Boeckh Michael; Carter Rachel A; Sandmaier Brenda M; Maris Michael B; Maloney David G; Martin Paul J; Storb Rainer F; Marr Kieren A
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Blood 2003;102(3):827-33.
-
2003: Flowers Mary E D; Martin Paul J
Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease.
Leukemia & lymphoma 2003;44(7):1141-6.
-
2003: Mielcarek Marco; Martin Paul J; Leisenring Wendy; Flowers Mary E D; Maloney David G; Sandmaier Brenda M; Maris Michael B; Storb Rainer
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 2003;102(2):756-62.
-
2003: Chien Jason W; Martin Paul J; Gooley Ted A; Flowers Mary E; Heckbert Susan R; Nichols W Garrett; Clark Joan G
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.
American journal of respiratory and critical care medicine 2003;168(2):208-14.
-
2003: Yu Xue-Zhong; Martin Paul J; Anasetti Claudio
CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(6):3002-6.
-
2003: Petersdorf E W; Anasetti C; Martin P J; Hansen J A
Tissue typing in support of unrelated hematopoietic cell transplantation.
Tissue antigens 2003;61(1):1-11.
-
2002: Kozaki Koichi; Kaminski Wolfgang E; Tang Jingjing; Hollenbach Stan; Lindahl Per; Sullivan Carol; Yu Jin-Chen; Abe Keith; Martin Paul J; Ross Russell; Betsholtz Christer; Giese Neill A; Raines Elaine W
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.
The American journal of pathology 2002;161(4):1395-407.
-
2002: Tseng Li-Hui; Chen Pei-Jer; Lin Ming-Tseh; Singleton Kentner; Martin Emily G; Yen Ai-Hsin; Martin Paul J; Hansen John A
Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism.
Journal of immunological methods 2002;267(2):151-6.
-
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
-
2002: Flowers Mary E D; Parker Pablo M; Johnston Laura J; Matos Alice V B; Storer Barry; Bensinger William I; Storb Rainer; Appelbaum Frederick R; Forman Stephen J; Blume Karl G; Martin Paul J
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Blood 2002;100(2):415-9.
-
2002: Koc Sibel; Leisenring Wendy; Flowers Mary E D; Anasetti Claudio; Deeg H Joachim; Nash Richard A; Sanders Jean E; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
-
2002: Gopal Ajay K; Rajendran Joseph G; Petersdorf Stephen H; Maloney David G; Eary Janet F; Wood Brent L; Gooley Theodore A; Bush Sharon A; Durack Lawrence D; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Blood 2002;99(9):3158-62.
-
2002: Warren E H; Otterud B E; Linterman R W; Brickner A G; Engelhard V H; Leppert M F; Martin P J; Riddell S R
Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens.
Tissue antigens 2002;59(4):293-303.
-
2002: Tseng L-H; Chen P-J; Lin M-T; Singleton K; Martin E G; Yen A-H; Chuang S-M; Martin P J; Hansen J A
Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFalpha and TNFbeta genes.
Tissue antigens 2002;59(4):280-6.
-
2002: Martin Paul J; Antin Joseph H; Weisdorf Daniel J; Paton Virginia; Horowitz Mary M
Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(6):295-302.
-
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
-
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
-
2002: Goerner Martin; Gooley Theodore; Flowers Mary E D; Sullivan Keith M; Kiem Hans-Peter; Sanders Jean E; Martin Paul J; Storb Rainer
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):47-56.
-
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
-
2001: Petersdorf E W; Hansen J A; Martin P J; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
The New England journal of medicine 2001;345(25):1794-800.
-
2001: Kansu E; Gooley T; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
-
2001: Lin M T; Gooley T; Hansen J A; Tseng L H; Martin E G; Singleton K; Smith A G; Mickelson E; Petersdorf E W; Martin P J
Absence of statistically significant correlation between disparity for the minor histocompatibility antigen-HA-1 and outcome after allogeneic hematopoietic cell transplantation.
Blood 2001;98(10):3172-3.
-
2001: Petersdorf E; Anasetti C; Martin P J; Woolfrey A; Smith A; Mickelson E; Malkki M; Lin M T; Hansen J A
Genomics of unrelated-donor hematopoietic cell transplantation.
Current opinion in immunology 2001;13(5):582-9.
-
2001: Ruffner K L; Martin P J; Hussell S; Nourigat C; Fisher D R; Bernstein I D; Matthews D C
Immunosuppressive effects of (131)I-anti-CD45 antibody in unsensitized and donor antigen-presensitized H2-matched, minor antigen-mismatched murine transplant models.
Cancer research 2001;61(13):5126-31.
-
2001: Al-Ghamdi H; Leisenring W; Bensinger W I; Nash R A; Storb R; Appelbaum F R; Martin P J
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest.
British journal of haematology 2001;113(2):461-9.
-
2001: Yu X Z; Bidwell S J; Martin P J; Anasetti C
Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(9):5835-9.
-
2001: Tseng L H; Chen P J; Lin M T; Shau W Y; Chaung S M; Martin P J; Hansen J A
Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese.
Tissue antigens 2001;57(4):318-24.
-
2001: Kaminski W E; Lindahl P; Lin N L; Broudy V C; Crosby J R; Hellström M; Swolin B; Bowen-Pope D F; Martin P J; Ross R; Betsholtz C; Raines E W
Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice.
Blood 2001;97(7):1990-8.
-
2001: Bensinger W I; Martin P J; Storer B; Clift R; Forman S J; Negrin R; Kashyap A; Flowers M E; Lilleby K; Chauncey T R; Storb R; Appelbaum F R
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
-
2001: Lorenz E; Schwartz D A; Martin P J; Gooley T; Lin M T; Chien J W; Hansen J A; Clark J G
Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(7):384-7.
-
2001: Pei J; Akatsuka Y; Anasetti C; Lin M T; Petersdorf E W; Hansen J A; Martin P J
Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(7):378-83.
-
2000: Koc S; Leisenring W; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
-
2000: Press O W; Eary J F; Gooley T; Gopal A K; Liu S; Rajendran J G; Maloney D G; Petersdorf S; Bush S A; Durack L D; Martin P J; Fisher D R; Wood B; Borrow J W; Porter B; Smith J P; Matthews D C; Appelbaum F R; Bernstein I D
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Blood 2000;96(9):2934-42.
-
2000: Crosby J R; Kaminski W E; Schatteman G; Martin P J; Raines E W; Seifert R A; Bowen-Pope D F
Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation.
Circulation research 2000;87(9):728-30.
-
2000: Dixon A E; Mandac J B; Madtes D K; Martin P J; Clark J G
Chemokine expression in Th1 cell-induced lung injury: prominence of IFN-gamma-inducible chemokines.
American journal of physiology. Lung cellular and molecular physiology 2000;279(3):L592-9.
-
2000: Dixon A E; Mandac J B; Martin P J; Hackman R C; Madtes D K; Clark J G
Adherence of adoptively transferred alloreactive Th1 cells in lung: partial dependence on LFA-1 and ICAM-1.
American journal of physiology. Lung cellular and molecular physiology 2000;279(3):L583-91.
-
2000: Sierra J; Storer B; Hansen J A; Martin P J; Petersdorf E W; Woolfrey A; Matthews D; Sanders J E; Storb R; Appelbaum F R; Anasetti C
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Bone marrow transplantation 2000;26(4):397-404.
-
2000: Clark J G; Mandac J B; Dixon A E; Martin P J; Hackman R C; Madtes D K
Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells.
Transplantation 2000;70(1):39-43.
-
2000: Yu X Z; Bidwell S J; Martin P J; Anasetti C
CD28-specific antibody prevents graft-versus-host disease in mice.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4564-8.
-
1999: Yu X Z; Bidwell S; Martin P J; Anasetti C
Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(9):4780-7.
-
1999: Tseng L H; Lin M T; Hansen J A; Gooley T; Pei J; Smith A G; Martin E G; Petersdorf E W; Martin P J
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1999;94(8):2911-4.
-
1999: Petersdorf E W; Mickelson E M; Anasetti C; Martin P J; Woolfrey A E; Hansen J A
Effect of HLA mismatches on the outcome of hematopoietic transplants.
Current opinion in immunology 1999;11(5):521-6.
-
1999: Martin P J; Rowley S D; Anasetti C; Chauncey T R; Gooley T; Petersdorf E W; van Burik J A; Flowers M E; Storb R; Appelbaum F R; Hansen J A
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
-
1999: Matthews D C; Appelbaum F R; Eary J F; Fisher D R; Durack L D; Hui T E; Martin P J; Mitchell D; Press O W; Storb R; Bernstein I D
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.
Blood 1999;94(4):1237-47.
-
1999: Dixon A E; Mandac J B; Martin P J; Madtes D K; Hackman R C; Clark J G
Alloreactive Th1 cells localize in lung and induce acute lung injury.
Chest 1999;116(1 Suppl):36S-37S.
-
1999: Matthews D C; Martin P J; Nourigat C; Appelbaum F R; Fisher D R; Bernstein I D
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Blood 1999;93(2):737-45.
-
1999: Woolfrey A E; Anasetti C; Petersdorf E W; Martin P J; Sanders J E; Hansen J A
Unrelated donor marrow transplantation for treatment of childhood hematologic malignancies-effect of HLA disparity and cell dose.
Cancer treatment and research 1999;101():25-51.
-
1999: Feinstein L C; Seidel K; Jocum J; Bowden R A; Anasetti C; Deeg H J; Flowers M E; Kansu E; Martin P J; Nash R A; Storek J; Etzioni R; Applebaum F R; Hansen J A; Storb R; Sullivan K M
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):369-78.
-
1998: Petersdorf E W; Gooley T A; Anasetti C; Martin P J; Smith A G; Mickelson E M; Woolfrey A E; Hansen J A
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.
Blood 1998;92(10):3515-20.
-
1998: Martin P J; Schoch G; Gooley T; Anasetti C; Deeg H J; Nash R; Sanders J; Storb R; Appelbaum F
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
-
1998: Tseng L H; Lin M T; Martin P J; Pei J; Smith A G; Hansen J A
Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA.
Tissue antigens 1998;52(4):305-11.
-
1998: Liu S Y; Eary J F; Petersdorf S H; Martin P J; Maloney D G; Appelbaum F R; Matthews D C; Bush S A; Durack L D; Fisher D R; Gooley T A; Bernstein I D; Press O W
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3270-8.
-
1998: Yu X Z; Martin P J; Anasetti C
Role of CD28 in acute graft-versus-host disease.
Blood 1998;92(8):2963-70.
-
1998: Clark J G; Madtes D K; Hackman R C; Chen W; Cheever M A; Martin P J
Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(4):1913-20.
-
1998: Chen W; Chatta G S; Rubin W D; Clark J G; Hackman R C; Madtes D K; Ligitt D H; Kusunoki Y; Martin P J; Cheever M A
T cells specific for a polymorphic segment of CD45 induce graft-versus-host disease with predominant pulmonary vasculitis.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):909-18.
-
1998: Morton A J; Gooley T; Hansen J A; Appelbaum F R; Bruemmer B; Bjerke J W; Clift R; Martin P J; Petersdorf E W; Sanders J E; Storb R; Sullivan K M; Woolfrey A; Anasetti C
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Blood 1998;92(2):394-401.
-
1998: Sullivan K M; Anasetti C; Horowitz M; Rowlings P A; Petersdorf E W; Martin P J; Clift R A; Walters M C; Gooley T; Sierra J; Anderson J E; Bjerke J; Siadak M; Flowers M E; Nash R A; Sanders J E; Appelbaum F R; Storb R; Hansen J A
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
Annals of the New York Academy of Sciences 1998;850():312-24.
-
1998: Kusunoki Y; Chen W; Martin P J
Prevention of marrow graft rejection without induction of graft-versus-host disease by a cytotoxic T-cell clone that recognizes recipient alloantigens.
Blood 1998;91(11):4038-44.
-
1998: Hansen J A; Gooley T A; Martin P J; Appelbaum F; Chauncey T R; Clift R A; Petersdorf E W; Radich J; Sanders J E; Storb R F; Sullivan K M; Anasetti C
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
-
1998: Martin P J; Gooley T; Anasetti C; Petersdorf E W; Hansen J A
HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):128-33.
-
1997: Pei J; Martin P J; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):142-9.
-
1997: Martin P J; Petersdorf E W; Anasetti C; Hansen J A
HLA homozygosity and the risk of graft-versus-host disease.
Tissue antigens 1997;50(2):119-23.
-
1997: Sierra J; Radich J; Hansen J A; Martin P J; Petersdorf E W; Bjerke J; Bryant E; Nash R A; Sanders J E; Storb R; Sullivan K M; Appelbaum F R; Anasetti C
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 1997;90(4):1410-4.
-
1997: Sierra J; Storer B; Hansen J A; Bjerke J W; Martin P J; Petersdorf E W; Appelbaum F R; Bryant E; Chauncey T R; Sale G; Sanders J E; Storb R; Sullivan K M; Anasetti C
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
-
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
-
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
-
1997: Petersdorf E W; Longton G M; Anasetti C; Mickelson E M; McKinney S K; Smith A G; Martin P J; Hansen J A
Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.
Blood 1997;89(5):1818-23.
-
1997: Mielcarek M; Martin P J; Torok-Storb B
Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.
Blood 1997;89(5):1629-34.
-
1996: Petersdorf E W; Longton G M; Anasetti C; Mickelson E M; Smith A G; Martin P J; Hansen J A
Definition of HLA-DQ as a transplantation antigen.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15358-63.
-
1996: Offner F; Schoch G; Fisher L D; Torok-Storb B; Martin P J
Mortality hazard functions as related to neutropenia at different times after marrow transplantation.
Blood 1996;88(10):4058-62.
-
1996: Martin P J
Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
Blood 1996;88(3):962-9.
-
1996: Martin P J; Nelson B J; Appelbaum F R; Anasetti C; Deeg H J; Hansen J A; McDonald G B; Nash R A; Sullivan K M; Witherspoon R P; Scannon P J; Friedmann N; Storb R
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
-
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
-
1995: Balduzzi A; Gooley T; Anasetti C; Sanders J E; Martin P J; Petersdorf E W; Appelbaum F R; Buckner C D; Matthews D; Storb R; Sullivan K M; Hansen J A
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
-
1995: Petersdorf E W; Longton G M; Anasetti C; Martin P J; Mickelson E M; Smith A G; Hansen J A
The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.
Blood 1995;86(4):1606-13.
-
1995: Press O W; Eary J F; Appelbaum F R; Martin P J; Nelp W B; Glenn S; Fisher D R; Porter B; Matthews D C; Gooley T
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
Lancet 1995;346(8971):336-40.
-
1995: Doney K C; Storb R; Beach K; Anasetti C; Deeg H J; Hansen J A; Martin P J; Nash R A; Schubert M M; Sullivan K M
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Transplantation 1995;60(1):55-8.
-
1995: Sivam G P; Martin P J; Reisfeld R A; Mueller B M
Therapeutic efficacy of a doxorubicin immunoconjugate in a preclinical model of spontaneous metastatic human melanoma.
Cancer research 1995;55(11):2352-6.
-
1995: Matthews D C; Appelbaum F R; Eary J F; Fisher D R; Durack L D; Bush S A; Hui T E; Martin P J; Mitchell D; Press O W
Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
Blood 1995;85(4):1122-31.
-
1995: Hansen J A; Mickelson E; Petersdorf E W; Anderson J; Sierra J; Martin P J; Anasetti C
Marrow transplants from unrelated donors.
Clinical transplants 1995;():279-89.
-
1995: Anasetti C; Petersdorf E W; Martin P J; Hansen J A
Marrow transplantation from unrelated volunteer donors.
Cancer treatment and research 1995;76():137-68.
-
1994: Gooley T A; Martin P J; Fisher L D; Pettinger M
Simulation as a design tool for phase I/II clinical trials: an example from bone marrow transplantation.
Controlled clinical trials 1994;15(6):450-62.
-
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
-
1994: Petersdorf E W; Stanley J F; Martin P J; Hansen J A
Molecular diversity of the HLA-C locus in unrelated marrow transplantation.
Tissue antigens 1994;44(2):93-9.
-
1994: Mickelson E M; Guthrie L A; Etzioni R; Anasetti C; Martin P J; Hansen J A
Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
Tissue antigens 1994;44(2):83-92.
-
1994: Hansen J A; Anasetti C; Petersdorf E; Clift R A; Martin P J
Marrow transplants from unrelated donors.
Transplantation proceedings 1994;26(3):1710-2.
-
1994: Busca A; Anasetti C; Anderson G; Appelbaum F R; Buckner C D; Doney K; Martin P J; Petersdorf E; Sanders J E; Hansen J A
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
-
1993: Smith A G; Petersdorf E W; Mickelson E; Guthrie L A; Regen L; Martin P J; Hansen J A
HLA-DRB1 first domain sequences of two new DR11 alleles and one novel DR4 allele.
Tissue antigens 1993;42(5):533-5.
-
1993: Press O W; Eary J F; Appelbaum F R; Martin P J; Badger C C; Nelp W B; Glenn S; Butchko G; Fisher D; Porter B
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
The New England journal of medicine 1993;329(17):1219-24.
-
1993: Martin P J
Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
The Journal of experimental medicine 1993;178(2):703-12.
-
1993: Petersdorf E W; Smith A G; Mickelson E M; Longton G M; Anasetti C; Choo S Y; Martin P J; Hansen J A
The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Blood 1993;81(7):1923-32.
-
1993: Mickelson E M; Anasetti C; Yoon Choo S; Longton G M; Petersdorf E W; Martin P J; Hansen J A
Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
Transplantation proceedings 1993;25(1 Pt 2):1239-40.
-
1993: Petersdorf E W; Smith A G; Mickelson E M; Longton G M; Anasetti C; Choo S Y; Martin P J; Hansen J A
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1230-1.
-
1993: Radich J P; Sanders J E; Buckner C D; Martin P J; Petersen F B; Bensinger W; McDonald G B; Mori M; Schoch G; Hansen J A
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):304-13.
-
1993: Beatty P G; Anasetti C; Hansen J A; Longton G M; Sanders J E; Martin P J; Mickelson E M; Choo S Y; Petersdorf E W; Pepe M S
Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.
Blood 1993;81(1):249-53.
-
1993: Press O W; Eary J; Badger C C; Appelbaum F R; Wiseman G; Matthews D; Martin P J; Bernstein I D
High-dose radioimmunotherapy of lymphomas.
Cancer treatment and research 1993;68():13-22.
-
1992: Petersdorf E W; Smith A G; Martin P J; Hansen J A
HLA-DRB1 first domain sequence for a novel DR4 allele designated DRB1*0413.
Tissue antigens 1992;40(5):267-8.
-
1992: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Davis J; Doney K; Hill H F; Stewart P; Sullivan K M
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
-
1992: Appelbaum F R; Matthews D C; Eary J F; Badger C C; Kellogg M; Press O W; Martin P J; Fisher D R; Nelp W B; Thomas E D
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.
Transplantation 1992;54(5):829-33.
-
1992: Martin P J
Animal experimentation relevant to human marrow transplantation.
Current opinion in oncology 1992;4(2):239-46.
-
1992: Matthews D C; Badger C C; Fisher D R; Hui T E; Nourigat C; Appelbaum F R; Martin P J; Bernstein I D
Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Cancer research 1992;52(5):1228-34.
-
1991: Mickelson E M; Masewicz S; Smith A; Petersdorf E; Nepom G T; Martin P J; Hansen J A
T-cell clones identify three distinct epitopes associated with HLA-Dw14.
Human immunology 1991;32(3):229-33.
-
1991: Odum N; Martin P J; Schieven G L; Norris N A; Grosmaire L S; Hansen J A; Ledbetter J A
Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells.
Human immunology 1991;32(2):85-94.
-
1991: Matthews D C; Appelbaum F R; Eary J F; Hui T E; Fisher D R; Martin P J; Durack L D; Nelp W B; Press O W; Badger C C
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.
Blood 1991;78(7):1864-74.
-
1991: Petersdorf E W; Smith A G; Haase A M; Martin P J; Hansen J A
Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing.
Tissue antigens 1991;38(4):169-77.
-
1991: Martin P J
Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.
Bone marrow transplantation 1991;8(3):217-23.
-
1991: Odum N; Martin P J; Schieven G L; Masewicz S; Hansen J A; Ledbetter J A
HLA-DR molecules enhance signal transduction through the CD3/Ti complex in activated T cells.
Tissue antigens 1991;38(2):72-7.
-
1991: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Calori E; Davis J; Doney K; Reichert T; Stewart P
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
-
1991: Martin P J; Schoch G; Fisher L; Byers V; Appelbaum F R; McDonald G B; Storb R; Hansen J A
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
Blood 1991;77(8):1821-8.
-
1991: Beatty P G; Hansen J A; Longton G M; Thomas E D; Sanders J E; Martin P J; Bearman S I; Anasetti C; Petersdorf E W; Mickelson E M
Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.
Transplantation 1991;51(2):443-7.
-
1991: Mickelson E M; Masewicz S A; Nepom G T; Martin P J; Hansen J A
Alloreactive T-cell clones identify multiple HLA-DQw3 variants.
Human immunology 1991;30(1):32-40.
-
1991: Odum N; Martin P J; Schieven G L; Hansen J A; Ledbetter J A
Signal transduction by HLA class II antigens expressed on activated T cells.
European journal of immunology 1991;21(1):123-9.
-
1991: Petersdorf E W; Smith A G; Mickelson E M; Martin P J; Hansen J A
Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.
Immunogenetics 1991;33(4):267-75.
-
1991: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Nelp W B; Levy R; Miller R; Fisher D; Matthews D
Radiolabeled antibody therapy of human B cell lymphomas.
Advances in experimental medicine and biology 1991;303():91-6.
-
1990: Zutter M M; Durnam D M; Hackman R C; Loughran T P; Kidd P G; Ashley R L; Petersdorf E W; Martin P J; Thomas E D
Secondary T-cell lymphoproliferation after marrow transplantation.
American journal of clinical pathology 1990;94(6):714-21.
-
1990: Anasetti C; Tan P; Hansen J A; Martin P J
Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.
The Journal of experimental medicine 1990;172(6):1691-700.
-
1990: Voltarelli J C; Corpuz S; Martin P J
In vitro comparison of two methods of T cell depletion associated with different rates of graft failure after allogeneic marrow transplantation.
Bone marrow transplantation 1990;6(6):419-23.
-
1990: Martin P J
The role of donor lymphoid cells in allogeneic marrow engraftment.
Bone marrow transplantation 1990;6(5):283-9.
-
1990: Anasetti C; Beatty P G; Storb R; Martin P J; Mori M; Sanders J E; Thomas E D; Hansen J A
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.
Human immunology 1990;29(2):79-91.
-
1990: Martin P J; Schoch G; Fisher L; Byers V; Anasetti C; Appelbaum F R; Beatty P G; Doney K; McDonald G B; Sanders J E
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Blood 1990;76(8):1464-72.
-
1990: Hansen J A; Anasetti C; Beatty P G; Martin P J; Sanders J E; Storb R; Thomas E D
Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.
Bone marrow transplantation 1990;6 Suppl 1():108-11.
-
1990: Tan P; Anasetti C; Martin P J; Hansen J A
Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(2):485-8.
-
1990: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Nelp W B; Krohn K A; Fisher D; Porter B; Thomas E D
High-dose radioimmunotherapy of B cell lymphomas.
Frontiers of radiation therapy and oncology 1990;24():204-13; discussion 225-7.
-
1990: Petersdorf E W; Griffith R L; Erlich H A; Mickelson E M; Smith A G; Nisperos B B; Martin P J; Hansen J A
Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes.
Immunogenetics 1990;32(2):96-103.
-
1989: Voltarelli J C; Przepiorka D; Shankar P; Kopecky K; Martin P J; Torok-Storb B
CD8+/DR+/CD25--T-lymphocytes associated with marrow graft failure.
Bone marrow transplantation 1989;4(6):647-52.
-
1989: Press O W; Farr A G; Borroz K I; Anderson S K; Martin P J
Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
Cancer research 1989;49(17):4906-12.
-
1989: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Levy R; Miller R; Brown S; Nelp W B; Krohn K A
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1027-38.
-
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
-
1989: Hansen J A; Anasetti C; Beatty P G; Martin P J; Thomas E D
Allogeneic marrow transplantation: the Seattle experience.
Clinical transplants 1989;():105-14.
-
1988: Martin P J; Clift R A; Fisher L D; Buckner C D; Hansen J A; Appelbaum F R; Doney K C; Sullivan K M; Witherspoon R P; Storb R
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
-
1988: Press O W; Martin P J; Thorpe P E; Vitetta E S
Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(12):4410-7.
-
1988: Martin P J; Hansen J A; Torok-Storb B; Durnam D; Przepiorka D; O'Quigley J; Sanders J; Sullivan K M; Witherspoon R P; Deeg H J
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.
Bone marrow transplantation 1988;3(5):445-56.
-
1988: Martin P J; Hansen J A; Torok-Storb B; Moretti L; Press O; Storb R; Thomas E D; Weiden P L; Vitetta E S
Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease.
Bone marrow transplantation 1988;3(5):437-44.
-
1988: Zutter M M; Martin P J; Sale G E; Shulman H M; Fisher L; Thomas E D; Durnam D M
Epstein-Barr virus lymphoproliferation after bone marrow transplantation.
Blood 1988;72(2):520-9.
-
1988: Press O W; Hansen J A; Farr A; Martin P J
Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes.
Cancer research 1988;48(8):2249-57.
-
1988: Martin P J; Hansen J A; Anasetti C; Zutter M; Durnam D; Storb R; Thomas E D
Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(2):149-52.
-
1987: Storb R; Weiden P L; Sullivan K M; Appelbaum F R; Beatty P; Buckner C D; Clift R A; Doney K C; Hansen J; Martin P J
Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin.
Blood 1987;70(1):116-21.
-
1986: Bolger G B; Sullivan K M; Storb R; Witherspoon R P; Weiden P L; Stewart P; Sanders J; Meyers J D; Martin P J; Doney K C
Second marrow infusion for poor graft function after allogeneic marrow transplantation.
Bone marrow transplantation 1986;1(1):21-30.
Sign-in to see more
